163 related articles for article (PubMed ID: 18677164)
1. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.
Hense HW; Koesters E; Wellmann J; Meisinger C; Völzke H; Keil U
Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):409-15. PubMed ID: 18677164
[TBL] [Abstract][Full Text] [Related]
2. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example.
van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):244-9. PubMed ID: 20195155
[TBL] [Abstract][Full Text] [Related]
4. The SCORE risk model applied to recent population surveys in Norway compared to observed mortality in the general population.
Lindman AS; Selmer R; Tverdal A; Pedersen JI; Eggen AE; Veierød MB
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):731-7. PubMed ID: 17001212
[TBL] [Abstract][Full Text] [Related]
5. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway.
Lindman AS; Veierød MB; Pedersen JI; Tverdal A; Njølstad I; Selmer R
Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):501-7. PubMed ID: 17667638
[TBL] [Abstract][Full Text] [Related]
6. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.
Marques-Vidal P; Rodondi N; Bochud M; Pécoud A; Hayoz D; Paccaud F; Mooser V; Waeber G; Vollenweider P
Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):402-8. PubMed ID: 18677163
[TBL] [Abstract][Full Text] [Related]
7. Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population.
Stenlund H; Lönnberg G; Jenkins P; Norberg M; Persson M; Messner T; Boman K; Pearson T; Wall S; Nyström L; Weinehall L
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):321-4. PubMed ID: 19357519
[TBL] [Abstract][Full Text] [Related]
8. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study.
Meisinger C; Koenig W; Baumert J; Döring A
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1186-92. PubMed ID: 18356554
[TBL] [Abstract][Full Text] [Related]
9. [Calibrating the SCORE cardiovascular risk chart for use in Spain].
Sans S; Fitzgerald AP; Royo D; Conroy R; Graham I
Rev Esp Cardiol; 2007 May; 60(5):476-85. PubMed ID: 17535758
[TBL] [Abstract][Full Text] [Related]
10. Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project.
Aspelund T; Thorgeirsson G; Sigurdsson G; Gudnason V
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):761-8. PubMed ID: 18043296
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
12. [Model for estimation of cardiovascular risk in Norway].
Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
[TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes mellitus in Augsburg--an epidemiological overview.
Meisinger C; Döring A; Heier M; Thorand B; Löwel H;
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S103-9. PubMed ID: 16032526
[TBL] [Abstract][Full Text] [Related]
14. SCORE should be preferred to Framingham to predict cardiovascular death in French population.
Marchant I; Boissel JP; Kassaï B; Bejan T; Massol J; Vidal C; Amsallem E; Naudin F; Galan P; Czernichow S; Nony P; Gueyffier F
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):609-15. PubMed ID: 20054289
[TBL] [Abstract][Full Text] [Related]
15. Regional disparities of hypertension prevalence and management within Germany.
Meisinger C; Heier M; Völzke H; Löwel H; Mitusch R; Hense HW; Lüdemann J
J Hypertens; 2006 Feb; 24(2):293-9. PubMed ID: 16508575
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease.
Homko CJ; Santamore WP; Zamora L; Shirk G; Gaughan J; Cross R; Kashem A; Petersen S; Bove AA
J Cardiovasc Nurs; 2008; 23(4):332-7. PubMed ID: 18596496
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease risk profiles among 'healthy' siblings of patients with early-onset cardiovascular disease: application of the new SCORE system.
Horan PG; Kamaruddin MS; Moore MJ; McCarty D; Spence MS; McGlinchey PG; Murphy G; Jardine TC; Patterson CC; McKeown PP
Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):521-5. PubMed ID: 17667642
[TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone therapy in Germany. Results of three national surveys from 1997 to 2003.
Heier M; Moebus S; Meisinger C; Jöckel KH; Völzke H; Döring A; Alte D
Maturitas; 2009 Jan; 62(1):9-15. PubMed ID: 19028032
[TBL] [Abstract][Full Text] [Related]
19. Obesity markers and estimated 10-year fatal cardiovascular risk in Switzerland.
Marques-Vidal P; Bochud M; Mooser V; Paccaud F; Waeber G; Vollenweider P
Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):462-8. PubMed ID: 19185476
[TBL] [Abstract][Full Text] [Related]
20. Living alone is associated with an increased risk of type 2 diabetes mellitus in men but not women from the general population: the MONICA/KORA Augsburg Cohort Study.
Meisinger C; Kandler U; Ladwig KH
Psychosom Med; 2009 Sep; 71(7):784-8. PubMed ID: 19592514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
